Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03174704 · ClinicalTrials.gov registry record
Medication Adherence Research in COPD Patients
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 314
- Enrollment target
NCT03174704: Completed study, sponsored by Johns Hopkins University.
NCT03174704 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 314 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03174704 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 314 participants
- Enrollment target
Study Summary
Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death, affects over 24 million people in the US and is the leading cause of disability with projected healthcare costs at almost $50 billion. The goal of this study is to identify novel and potentially powerful targets for behavioral interventions in COPD which has been understudied despite its tremendous detrimental impact on overall public health.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2023-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03174704
The ClinicalTrials.gov registry entry for NCT03174704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03174704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03174704 about?
NCT03174704 is a clinical study titled "Medication Adherence Research in COPD Patients". Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death, affects over 24 million people in the US and is the leading cause of disability with projected healthcare costs at almost $50 billion. The goal of this study is to identify novel and potentially powerful targets for be...
What is the current status of trial NCT03174704?
This trial is currently completed. The enrollment target is 314 participants. The study started on 2017-05-01. Estimated completion is 2023-03-31.
Who is sponsoring clinical trial NCT03174704?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.